FIELD: medicine. SUBSTANCE: means has hardly soluble agent and carrier agent having hydrophilic phase having dimethyl sorbide and/or lower alkyl-alcane ester, lipophilic phase and surfactant substance. Cyclosporin or macrolides are useable as active agent. EFFECT: enhanced effectiveness of treatment; improved bioavailability properties. 5 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION, USING CARBOXYLIC ACID FOR STABILIZING MACROLIDE IN THIS COMPOSITION AND METHOD FOR STABILIZING MACROLIDE | 1995 |
|
RU2292887C2 |
| PRELIMINARY PREPARED EMULSION CONCENTRATES CONTAINING CYCLOSPORINE OR MACROLIDE | 1999 |
|
RU2235554C2 |
| SOFT GELATINOUS CAPSULE (VARIANTS) AND METHOD OF ITS MAKING | 1994 |
|
RU2140783C1 |
| PHARMACEUTICAL COMPOSITION, PRODUCT OF TRANSESTERIFICATION OF CORN OIL WITH GLYCEROL AND METHOD OF ITS PREPARING | 1992 |
|
RU2143919C1 |
| CYCLOSPORIN-CONTAINING AND PRACTICALLY OIL-FREE COMPOSITIONS | 2000 |
|
RU2249461C2 |
| PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2639482C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORIN DERIVATIVE AND A METHOD OF ITS PREPARING | 1993 |
|
RU2126263C1 |
| NEW PHARMACEUTICAL COMPOSITIONS | 1999 |
|
RU2240121C2 |
| COMPOSITION FOR TOPICAL USE | 1995 |
|
RU2181592C2 |
| N-BENZOYLSTAUROSPORIN-CONTAINING SPONTANEOUSLY DISPERSING COMPOSITIONS | 2000 |
|
RU2266121C2 |
